Price target lifted on Cytokinetics By: MarketMinute.com Stock News December 31, 2014 at 16:29 PM EST Roth Capital lifted its price target on Cytokinetics (Nasdaq: CYTK) from $13 to $18 sending the stock price up $1.11 to close at $8.01. Related Stocks: Cytokinetics